A Randomized, Double-blind, Placebo-controlled, Phase 2b study to Evaluate Safety and Efficacy of DUR-928 in Subjects with Alcoholic Hepatitis

Investigator: David Victor, MD

Study Coordinator:

Status: Enrolling

ClinicalTrials.gov Number: NCT04563026

Phone:

Protocol Number: PRO00030634

Description

This is a randomized, double-blind, placebo-controlled, phase 2b clinical Trial evaluating Safety and Efficacy of DUR-928 (an experimental medication) in Patients with Alcoholic Hepatitis (AH).
More to Explore